ELV
Elevance Health, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 5 ▲ 1 insider buy $869.5K at $289.84
- Mar 6 to Mar 12 ▼ 2 days of insider sells: $918.1K by 2 insiders, avg $284.94
- May 19 ▼ 1 insider sell $617.2K at $403.13
- Jun 11 to Jun 12 ▼ 2 days of insider sells: $209.4K by 2 insiders, avg $402.76
- Jun 30 ▲ 8 funds open new positions (13F)
- Jul 17 ▲ 2 insiders buy $1.4M at $367.32
- Jul 20 ▼ Ro Khanna sold $1,001 - $15,000, last disclosed Aug 12
- Aug 17 to Aug 20 2 court rulings: Imagine 360 Administrators, LLC v. Elevance Health, Inc.; WIEGMAN v. ELEVANCE HEALTH, INC.
- Oct 21 ▲ Elevance Health reported Q3 2026 adjusted diluted EPS of $6.99, sign…
- Oct 21 ▲ Earnings: ELV Q3 2026 Earnings: EPS $6.99 (+47.8% vs est)
- Oct 22 ▼ 1 insider sell $4.7M at $440.13
- Nov 5 ▼ 1 insider sell $572.0K at $440.00
Signal stack
Where each data set points today.
- InsidersBEARISH
3 insiders bought $2.2M at an average $332.76. 6 insiders sold $7.0M. Price is 34% above their cost.
- InstitutionsBULLISH
Q2 2026: 87 added (8 new), 43 trimmed or exited. Largest new: Diamond Hill Capital Management, (Investment Advisor) $96.6M, Sound Shore Management /Ct/ $94.2M.
- AnalystsBULLISH
19 of 28 rate it Buy or better. Median target $492.00 (+11%).
- Short sellersSTEADY
Short interest −11.5% to 4.54M shares. 3.3 days to cover, ≈2.1% of shares.
- TrendUPTREND
7% above its 50-day average.
- SocialQUIET
Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup is alerting.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| NORGES BANK | ADD | $1.5B |
| FMR LLC | ADD | $1.2B |
| CITIGROUP INC | DOUBLED | $810.9M |
| GOLDMAN SACHS GROUP INC | ADD | $775.6M |
| BANK OF AMERICA CORP /DE/ | TRIM | $698.5M |
| Amundi | TRIM | $636.0M |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | TRIM | $591.1M |
| CITADEL ADVISORS LLC | TRIM | $350.5M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
28 analystsPrice is inside the target range. Median implies +11%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 27, 2026 | Wells Fargo MAINTAIN | Overweight |
| Oct 23, 2026 | TD Cowen MAINTAIN | Buy |
| Oct 22, 2026 | UBS MAINTAIN | Buy |
| Oct 22, 2026 | Guggenheim MAINTAIN | Buy |
| Oct 22, 2026 | Morgan Stanley MAINTAIN | Equal-Weight |
| Oct 22, 2026 | RBC Capital MAINTAIN | Sector Perform |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
LAVU RATNAKAR EVP & Chief Digital Info Ofr Nov 5, 2026 | SELL | $572.0K |
Kaye Mark EVP & CFO Oct 22, 2026 | SELL | $173.6K |
Kaye Mark EVP & CFO Oct 22, 2026 | SELL | $139.7K |
Kaye Mark EVP & CFO Oct 22, 2026 | SELL | $724.1K |
Kaye Mark EVP & CFO Oct 22, 2026 | SELL | $244.8K |
Kaye Mark EVP & CFO Oct 22, 2026 | SELL | $105.2K |
Kaye Mark EVP & CFO Oct 22, 2026 | SELL | $509.5K |
Kaye Mark EVP & CFO Oct 22, 2026 | SELL | $757.6K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026Washington
SecBot reports
19 filings · 2 bullish · 1 bearish · 1 mixed · 15 neutral- NEUTRAL 8-KNov 10, 2026
Elevance Health filed an 8-K to reaffirm its full-year 2026 guidance during investor meetings. The…
This filing contains no new information beyond a routine reaffirmation of existing guidance. Monitor the next quarterly earnings release for any actual performance versus these targets.
- NEUTRAL 144Nov 5, 2026
Elevance Health officer Lavu Ratnakar filed a Form 144 notice of intent to sell 1,300 shares of…
The filing is a routine insider intent-to-sell notice for a modest number of shares. No material impact on the stock is expected. Monitor for any subsequent Form 4 filings to confirm execution.
- NEUTRAL S-3ASROct 28, 2026
Elevance Health filed an automatic shelf registration (S-3ASR) to register an unlimited amount of…
Monitor for a prospectus supplement that would specify the size, maturity, and coupon of any actual debt issuance. The shelf itself is routine for a large investment-grade issuer and does not signal…
- NEUTRAL 144Oct 22, 2026
Elevance Health officer Mark Kaye filed a Form 144 notice of intent to sell 10,584 shares of…
This is a routine Form 144 filing by an officer selling shares acquired through equity compensation. No material change in company outlook is implied. Monitor for any subsequent Form 4 filings to…
All ELV filing & press-release reports (19)
- 8-K reportNov 10, 2026
- 144 reportNov 5, 2026
- S-3ASR reportOct 28, 2026
- 144 reportOct 22, 2026
- 8-K reportOct 21, 2026
- INST-CLUSTER reportOct 20, 2026
- 8-K reportSep 10, 2026
- INST-CLUSTER reportAug 27, 2026
- COURT-RULING reportAug 20, 2026
- COURT-RULING reportAug 17, 2026
- GOVT-CONTRACT reportJul 23, 2026
- CLUSTER reportJul 17, 2026
- 8-K reportJul 15, 2026
- CLUSTER reportJun 15, 2026
- 8-K reportJun 10, 2026
- 8-K reportApr 22, 2026
- DEFA14A reportMar 27, 2026
- CLUSTER reportMar 5, 2026
- CLUSTER reportMar 5, 2026